Risk factors of mortality in invasive pneumococcal disease;Factores relacionados con la mortalidad de la enfermedad neumocócica invasiva

Medicina Clinica

Volumn 123, Issue 15, 2004, Pages 575-577

  Rondón, Lucía Barahona ^a,c   García, Francisco Soriano ^a   Granizo Martínez, Juan José ^b   Santos O'Connor, Francisco ^a   López Durán, Juan Carlos ^a   Fernández Roblas, Ricardo ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b Departaments of Clinical Neurophysiology   (Spain)

^c Fundacion Carolina   (Spain)

Author keywords

Invasive pneumococcal disease; Mortality; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; ERYTHROMYCIN; LEVOFLOXACIN; PENICILLIN G; TETRACYCLINE; VANCOMYCIN;

ACIDOSIS; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTHRITIS; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; CONTROLLED STUDY; DISEASE SEVERITY; EMERGENCY HEALTH SERVICE; HUMAN; LEUKOCYTOSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENINGITIS; MICROBIOLOGY; MORTALITY; PAIN; PLEURISY; PNEUMONIA; RELAPSE; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEPSIS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TACHYPNEA; TRACHEOSTOMY; UNCONSCIOUSNESS; UNIVERSITY HOSPITAL;

EID: 9944257520     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13068002     Document Type: Article

References (10)

1. Vaqueiro SM, Sampere VM, Font CB, Serrate SG, Fontanals AD, Segura PF. Bacteremia neumocócica en pacientes mayores de 65 años. Estudio de 161 casos. Med Clin (Barc) 2001;117:241-5.
2. Maddox JM, Winter JH. Pneumococcal bacteraemia: clinical and microbiological epidemiology in Dundee, Scotland. J Infect 2003;47:12-8.
3. Turett GS, Blum S, Fazal BA, Justman JE, Telzak EE. Penicillin resistence and other predictors of mortality in pneumococcal bacteremia in a population with high human inmmunodeficiency virus seroprevalence. Clin Infect Dis 1999;29:321-7.
4. Metlay JP, Hoffman I, Cetron MS, Fine MJ, Farley MM, Withney C, et al. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumoniae. Clin Infect Dis 2000;30:520-8.
5. Moroney JF, Fiore AE, Harrison LH, Patterson JE, Farley MM, Jorgensen JH, et al. Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance. Clin Infect Dis 2001;33:797-805.
6. Pallarés R, Liñares J, Vadillo M, Cabellos C, Manresa F, Viladrich PF, et al. Resistance to penicillin and cephalosporin and mortality from sever pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995;333:474-80.
7. Plouffe FJ, Breiman RF, Facklam RR. Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. JAMA 1996;275:194-8.
8. Feikin D, Schuchat A, Kolczack M, Barret N, Harrison L, Lefkowitz L, et al. Mortality from invasive pneumococcal pneumoniae in the era of antibiotic resistance, 1995-1997. Am J Public Health 2000;90:223-9.
9. Nava JM, Bella F, Garau J, Lite J, Morera MA, Marti C, et al. Predictive factors for invasive disease due to penicillin resistant Streptococcus pneumoniae: a population based study. Clin Infect Dis 1994;19:884-90.
10. Cornejo GM, Salinas GJ. Tema de revisión: neumonía neumocócica. Revista Virtual del CIEM Enero 1996 [consultado 16/07/2003]. Disponible en: http://www.ucsm.edu.pe/ciemucsm/pages/neneu.htm